← Back to RCUS

ARCUS BIOSCIENCES INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 05/08/2026Sep 2025Filed 28/10/2025Jun 2025Filed 05/08/2026Mar 2025Filed 05/08/2026Sep 2024Filed 28/10/2025Jun 2024Filed 28/10/2025Mar 2024Filed 28/10/2025
$33$7$6$8$8$7$11$10
−$91−$128−$135$0−$112−$92−$93−$4
−$0.72−$1.02−$1.27$0.00−$1.14−$1.00−$1.02−$0.05
12612510710798919186

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.